NCT00003425 · Interventional trial
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
Overall registry status Completed
Phase 1 · Phase 2
Conditions Breast Cancer, Leukemia, Lymphoma, Neuroblastoma, Ovarian Cancer, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific
Delaware Valley sites
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory